Imatinib resistance: obstacles and opportunities.

Litzow, Mark R

Imatinib resistance: obstacles and opportunities. [electronic resource] - Archives of pathology & laboratory medicine May 2006 - 669-79 p. digital

Publication Type: Journal Article; Review

1543-2165

10.5858/2006-130-669-IROAO doi


Antineoplastic Agents--pharmacology
Benzamides
Drug Resistance, Neoplasm--drug effects
Fusion Proteins, bcr-abl--antagonists & inhibitors
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Mutation
Piperazines--pharmacology
Protein-Tyrosine Kinases--antagonists & inhibitors
Pyrimidines--pharmacology